XML 17 R54.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2014

Schedule of weighted average assumptions as of grant date used to determine fair value of options granted

	2014			2013			2012

Risk-free interest rate		2.08	%		1.35	%		1.29	%
Expected term (years)		7.00			7.00			7.00
Expected stock price volatility		28.04	%		33.93	%		40.19	%
Dividend yield		2.49	%		1.77	%		0.42	%

Summary of stock option activity

Options (restated for stock dividends and splits)	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value

Outstanding, beginning of year		402,139		$	13.79
Granted		31,327			16.11
Exercised		(6,950	)		9.50
Forfeited or expired		(48,726	)		18.48

Outstanding at end of year		377,790		$	13.46		4.9	$	2,817
Exercisable at year end		288,938		$	13.24		3.8	$	2,219
Fully vested and expected to vest		370,575		$	13.44		4.8	$	2,772

Schedule of information related to the 2007 stock incentive plan and the 2003 plan

	2014		2013		2012

Intrinsic value of options exercised	$	55	$	265	$	124
Cash received from option exercises		66		389		120
Tax benefit realized from option exercises		—		25		12
Weighted average (per share) fair value of options granted		3.78		4.16		4.88

Summary of changes in the nonvested shares

	Shares			Weighted Average Grant Date Fair Value

Nonvested at January 1, 2014		105,283		$	12.85
Granted		34,337			16.30
Vested		(47,697	)		11.43
Forfeited		—			—

Nonvested at December 31, 2014		91,923		$	14.88

Schedule of shares awarded

Quarter		Shares		Price per Share

2012	1Q		8,750	$	9.29
	2Q		7,200	$	11.83
	3Q		7,200	$	11.58
	4Q		7,200	$	12.25
2013	1Q		7,200	$	13.38
	2Q		26,100	$	13.79
2014	2Q		21,780	$	16.53

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details